Chief Commercial Officer, President, Global Biopharmaceuticals Business
Angela Hwang is the Chief Commercial Officer and President of the Global Biopharmaceuticals Business at Pfizer and a member of its Executive Leadership Team. Her organization of 26,000 colleagues is responsible for bringing over 600 innovative medicines and products to patients. Angela leads 6 commercial business units, reaching patients in more than 185 countries. Together, these businesses strive to deliver transformational medicines that address major global health priorities in cancer, rare disease, inflammation & immunology, primary care, infectious diseases, and preventative care with vaccines.
Angela has been with Pfizer since 1997 , working across all geographies and therapeutic areas. She is motivated by the common purpose that all Pfizer colleagues share, to bring breakthroughs to patients, regardless of where they are in the world. Her childhood as an Asian girl growing up in apartheid South Africa, defined her worldview and underscored the importance of equity in everything she does today.
In addition to UPS, Angela sits on the boards of EFPIA (European Federation of Pharmaceutical Industries and Associations), as well as the Pfizer Foundation, a charitable organization that addresses global health challenges and the US China Business Council.
Having always been curious about transformation and the art of the possible, in 2019, Angela launched Diverse Perspectives, a podcast series where she hosts global thought leaders pioneering change across a variety of industries.
Angela joined the UPS Board of Directors in 2020 and serves on the Audit Committee.
Angela received her Bachelor of Science in Microbiology and Biochemistry from the University of Cape Town and MBA from Cornell University, and is a strong advocate for women’s leadership and sustainable global health equity.